Using the likelihood ratio to evaluate allowable total error - An example with glycated hemoglobin (HbA1c)

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 9, 2015, Pages 1459-1464

  Åsberg, Arne ^a   Odsæter, Ingrid Hov ^a,b   Carlsen, Sven Magnus ^a,b   Mikkelsen, Gustav ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

assessment; diagnostic errors; glycosylated; healthcare quality; hemoglobin A; logistic regression

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; ANALYTICAL ERROR; ARTICLE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; ENDOCRINE FUNCTION TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; MEASUREMENT ERROR; PREDICTOR VARIABLE; PRIORITY JOURNAL; ADOLESCENT; AGED; BLOOD; BLOOD ANALYSIS; METHODOLOGY; MIDDLE AGED; PROCEDURES; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; RESEARCH DESIGN; YOUNG ADULT;

EID: 84938500260     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-1125     Document Type: Article

References (22)

1. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet 2005;365:1500-5.
2. Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press, 2001.
3. Klee GG. Establishment of outcome-related analytic performance goals. Clin Chem 2010;56:714-22.
4. Little RR, Rohlfing CL, Sacks DB. Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem 2011;57:205-14.
5. Gillett MJ. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-34.
6. Clin Biochem Rev 2009;30:197-200.
7. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO Consultation. Geneva: World Health Organization, 2011:6-9.
8. National Glycohemoglobin Standardization Program. NGSP News. Available from: http://www.ngsp.org/news.asp. Accessed 18 September, 2014.
9. Westgard QC. Quality requirements. Available from: http://www. westgard.com/biodatabase1.htm. Accessed 18 September, 2014.
10. Rohlfing CL, Parvin CA, Sacks DB, Little RR. Comparing analytic performance criteria: evaluation of HbA1c certification criteria as an example. Clin Chim Acta 2014;433:259-63.
11. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation. Geneva: World Health Organization, 2006:3.
12. Martensson A, Rustad P, Lund H, Ossowicki H. Creatininium reference intervals for corrected methods. Scand J Clin Lab Invest 2004;64:439-41.
13. NOKLUS. Available from: http://www.noklus.no/English.aspx. Accessed 18 September, 2014.
14. Labquality. Available from: http://www.labquality.fi/?lang=en. Accessed 18 September, 2014.
15. Albert A. On the use and computation of likelihood ratios in clinical chemistry. Clin Chem 1982;28:1113-9.
16. Royston P, Sauerbrei W. Building multivariable regression models with continuous covariates in clinical epidemiology-with an emphasis on fractional polynomials. Methods Inf Med 2005;44:561-71.
17. Oosterhuis WP. Gross overestimation of total allowable error based on biological variation. Clin Chem 2011;57:1334-6.
18. Bolann BJ, Asberg A. Analytical quality goals derived from the total deviation from patients' homeostatic set points, with a margin for analytical errors. Scand J Clin Lab Invest 2004;64:443-50.
19. Weykamp CW, Mosca A, Gillery P, Panteghini M. The analytical goals for hemoglobin A(1c) measurement in IFCC units and National Glycohemoglobin Standardization Program units are different. Clin Chem 2011;57:1204-6.
20. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Geneva: World Health Organization, 1999:52.
21. Petersen PH, Jorgensen LG, Brandslund I, De Fine Olivarius N, Stahl M. Consequences of bias and imprecision in measurements of glucose and HbA1c for the diagnosis and prognosis of diabetes mellitus. Scand J Clin Lab Invest Suppl 2005;240:51-60.
22. Tankova T, Chakarova N, Dakovska L, Atanassova I. Assessment of HbA1c as a diagnostic tool in diabetes and prediabetes. Acta Diabetol 2012;49:371-8.